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CORRESPONDENCE 
Generic prescribing for epilepsy. Is it safe? 
Dear Sir, 
The report by Crawford et al makes little mention of 
sources of error in their study. The General Practices 
involved were selected twice; first by responding to 
the research team at all, and secondly by speed of 
response. Only 40 of 556 Practices made it over both 
hurdles! This would seem an effective means of se- 
lecting 40 Practices with an enthusiastic interest in 
epilepsy. What were the policies of the Practices who 
entered the study on generic prescribing for epilepsy? 
From these practices 2285 people with epilepsy 
were contacted and asked to complete a question- 
naire, of whom 58.8% responded. A switch of anti- 
convulsant, from generic to brand or brand to generic, 
was experienced by 251 people but we are not told 
from the GPs’ records how many switches actually 
occurred or what proportion of switches were generic 
to brand. Patients who perceived problems would be 
more likely to respond to the questionnaire and to 
remember switches. 
The basis for the claim that switches produced sig- 
nificant health problems is not clear. Increased sick 
leave and loss of employment are discussed, but the 
study gives no data on whether patients who perceive 
problems during the switch consulted their GPs or 
missed time off work. The basis for the GPs ‘validat- 
ing’ problems after the switch is not clear. 
A critical eye might perceive that, starting with the 
epilepsy population of the Yorkshire region-perhaps 
20000 patients, this study identified 21 people who 
felt poorly at a time which coincided with a switch 
of medication. 
Epilepsy is a very variable condition. Seizures 
change in frequency unpredictably even on constant 
medication. People with epilepsy are as subject to 
the placebo influence of changes in their medication 
as anyone else. UncontrolIed and highly selected re- 
ports do nothing to inform the debate about generic 
prescribing. 
RICHARD BEACH 
Consultant Paediatrician 
and 
RICHARD READING 
Consultant Community Paediatrician 
Norfolk & Norwich, 
Health Care NHS Trust, 
Brunswick Road, 
Norwich, 
Norfolk, 
NRl 3SR 
Post-mortem determination of anticonvuisant 
concentrations and lung oedema in the sudden, 
unexpected death of epileptics 
Dear Sir, now?‘. We would like to comment on this. Referring 
to a previous paper’ the authors questionned the relia- 
In Seizure 1996; 5: 235-238, Lina Nashef and bility of antiepileptic drug concentrations in posfmor- 
J.W.A.S. Sander published an article entitled: ‘Sud- tul samples. But, four recent findings strongly favour 
den unexpected deaths in epilepsy-where are we the relevance and reproducibility of post-mortem de- 
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terminations in the serum and in the brain: (1) The 
relationship between the postmortal serum concen- 
trations of phenytoin (PHT)2, phenobarbital (PBd, 
carbamazepine (CBZ)3 or its anticonvulsive metabo- 
lite CBZ-10, 1 I-epoxide (CE)3 and the correspond- 
ing postmortal frontal cortical concentrations was 
linear or nearly linear with high correlation coef- 
ficients of 0.987, 0.977, 0.976, and 0.954, respec- 
tively. (2) Different time intervals between death and 
sampling during autopsy, obviously, did not signifi- 
cantly influence the protein-binding or the concentra- 
tion ratios brain cortex/serum free of the four com- 
pounds4*?. (3) The postmortal free PHT and PB serum 
fractions (expressed in %) of epileptic patients suc- 
cumbed from sudden, unexpected, unexplained death 
(SUUD) (in preparation) were comparable with the 
values of living and otherwise healthy epileptics4. 
(4) The analytical data of specimens obtained from 
neurosurgical resections were in good agreement with 
those from brains of deceased epileptics regarding the 
concentration ratios brain cortex/serum free for PHT, 
PB, CBZ or CE (reviewed by Rambeck et ~1~). 
Nashef and Sander emphasized in the context of 
SUUD of epileptic persons that ‘oedema of organs, 
particularly lungs, bronchial secretions or minor as- 
piration are not deemed sufficient to cause death’. 
Indeed almost all autopsied epileptic and also non- 
epileptic persons exhibit lung oedema of a slight or 
moderate grade which is insufficient to explain the 
cause of death. But, in SUUD each lung oedema 
should be histologically controlled and quantified by 
weighing both pulmonary lobes. So, in very rare 
cases, of our series a severe central (neurogenic) lung 
oedema could be proved indicative most probably as 
the cause of sudden, unexpected death. In this context 
we observed two adult epileptic patients with SUUD, 
whose lung weights amounted to 370 and 200%, re- 
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spectively, compared to age- and sex-matched con- 
trol@. 
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